
Joshua Mark Galanter MD
Asthma & COPD, Critical Care Medicine, Interstitial Lung Diseases, Clinical Pharmacology
Senior Medical Director, Early Clinical Development Genentech, a member of the Roche Group
Join to View Full Profile
1 DNA WaySouth San Francisco, CA 94080
Phone+1 650-438-9536
Dr. Galanter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California (San Francisco) School of MedicineFellowship, Clinical Pharmacology, 2007 - 2009
- University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 2006 - 2009
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2003 - 2006
- Harvard Medical SchoolClass of 2003
Certifications & Licensure
- CA State Medical License 2004 - 2024
Publications & Presentations
PubMed
- Mechanistic Physiologically Based Pharmacokinetic Modeling of Dry Powder and Nebulized Formulations of Orally Inhaled TMEM16A Potentiator GDC-6988.Rui Zhu, Ian Sorrell, Fang Ma, Miaoran Ning, Yoen-Ju Son
CPT. 2025-04-01 - 1 citationsSerious Infection Rates Among Patients with Select Autoimmune Conditions: A Claims-Based Retrospective Cohort Study from Taiwan and the USA.Wen-Nan Huang, Ching-Yi Chuo, Ching-Heng Lin, Yi-Ming Chen, Wei-Szu Lin
Rheumatology and Therapy. 2023-04-01 - 7 citationsAstegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial.Michael Waters, James A McKinnell, Andre C Kalil, Greg S Martin, Timothy G Buchman
Critical Care Medicine. 2023-01-01
Press Mentions
- Cultural Differences May Leave Their Mark on DNAJanuary 10th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: